Net Income (Loss) Attributable to Parent in USD of Vicapsys Life Sciences, Inc. from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Vicapsys Life Sciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2019 to Q3 2024.
  • Vicapsys Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2024 was -$236K, a 2.01% increase year-over-year.
  • Vicapsys Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2024 was -$1.35M, a 24.8% decline year-over-year.
  • Vicapsys Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$1.18M, a 20% decline from 2022.
  • Vicapsys Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$985K, a 316% decline from 2021.
  • Vicapsys Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$237K, a 69.1% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Vicapsys Life Sciences, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.35M -$236K +$4.83K +2.01% 01 Jul 2024 30 Sep 2024 10-Q 10 Jan 2025
Q2 2024 -$1.35M -$190K -$54.4K -40.1% 01 Apr 2024 30 Jun 2024 10-Q 10 Jan 2025
Q1 2024 -$1.3M -$327K -$116K -54.8% 01 Jan 2024 31 Mar 2024 10-Q 10 Jan 2025
Q4 2023 -$1.18M -$595K -$102K -20.7% 01 Oct 2023 31 Dec 2023 10-K 21 Oct 2024
Q3 2023 -$1.08M -$240K -$95.3K -65.7% 01 Jul 2023 30 Sep 2023 10-Q 10 Jan 2025
Q2 2023 -$985K -$136K +$44.4K +24.6% 01 Apr 2023 30 Jun 2023 10-Q 10 Jan 2025
Q1 2023 -$1.03M -$211K -$44.2K -26.5% 01 Jan 2023 31 Mar 2023 10-Q 10 Jan 2025
Q4 2022 -$985K -$493K -$389K -374% 01 Oct 2022 31 Dec 2022 10-K 21 Oct 2024
Q3 2022 -$596K -$145K -$33.9K -30.5% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$562K -$180K -$108K -150% 01 Apr 2022 30 Jun 2022 10-Q 14 Nov 2023
Q1 2022 -$454K -$167K -$217K -433% 01 Jan 2022 31 Mar 2022 10-Q 14 Nov 2023
Q4 2021 -$237K -$104K -$23.3K -28.9% 01 Oct 2021 31 Dec 2021 10-K 14 Apr 2023
Q3 2021 -$214K -$111K -$22K -24.6% 01 Jul 2021 30 Sep 2021 10-Q 21 Nov 2022
Q2 2021 -$192K -$72.1K +$160K +68.9% 01 Apr 2021 30 Jun 2021 10-Q 21 Nov 2022
Q1 2021 -$351K $50.2K +$415K 01 Jan 2021 31 Mar 2021 10-Q 21 Nov 2022
Q4 2020 -$766K -$80.5K +$169K +67.7% 01 Oct 2020 31 Dec 2020 10-K 16 Mar 2022
Q3 2020 -$935K -$89.2K +$380K +81% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$1.32M -$232K +$16.5K +6.63% 01 Apr 2020 30 Jun 2020 10-Q 20 Sep 2021
Q1 2020 -$1.33M -$364K +$78.2K +17.7% 01 Jan 2020 31 Mar 2020 10-Q 20 Sep 2021
Q4 2019 -$1.41M -$250K 01 Oct 2019 31 Dec 2019 10-K 17 Sep 2021
Q3 2019 -$469K 01 Jul 2019 30 Sep 2019 10-Q 13 Sep 2021
Q2 2019 -$248K 01 Apr 2019 30 Jun 2019 10-Q 13 Sep 2021
Q1 2019 -$443K 01 Jan 2019 31 Mar 2019 10-Q 13 Sep 2021

Vicapsys Life Sciences, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1.18M -$197K -20% 01 Jan 2023 31 Dec 2023 10-K 21 Oct 2024
2022 -$985K -$748K -316% 01 Jan 2022 31 Dec 2022 10-K 21 Oct 2024
2021 -$237K +$529K +69.1% 01 Jan 2021 31 Dec 2021 10-K 14 Apr 2023
2020 -$766K +$644K +45.7% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2022
2019 -$1.41M 01 Jan 2019 31 Dec 2019 10-K 17 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.